K131544

Substantially Equivalent

COBAS C BILIRUBIN TOTAL GEN.3

Applicant: Roche Diagnostics
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 2013-05-29
Decision date: 2013-07-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.